Cargando…
Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
The nematode Spirocerca lupi is a major canine parasite in warm regions of the world, classically causing parasitic nodules in the esophagus, aortic aneurysms, and spondylitis. This study evaluated the preventive efficacy of monthly treatment with imidacloprid 10%/moxidectin 2.5% spot-on (Advocate®...
Autores principales: | Le Sueur, Christophe, Bour, Sophie, Schaper, Roland |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975917/ https://www.ncbi.nlm.nih.gov/pubmed/20706736 http://dx.doi.org/10.1007/s00436-010-2022-8 |
Ejemplares similares
-
Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis
por: Rojas, Alicia, et al.
Publicado: (2017) -
Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study
por: Segev, Gilad, et al.
Publicado: (2018) -
Spirocerca lupi Proteomics and Its Role in Cancer Development: An Overview of Spirocercosis-Induced Sarcomas and Revision of Helminth-Induced Carcinomas
por: Porras-Silesky, Catalina, et al.
Publicado: (2021) -
Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
por: Otranto, Domenico, et al.
Publicado: (2021) -
Effect of Therapy by Using Advocate Spot-On Combination (Imidacloprid 10% and Moxidectin 2.5%) on Subcutaneous Dirofilariosis in Dogs
por: Paran, Radmila Dobešová, et al.
Publicado: (2011)